Transaction · 0001578563-25-000028

Sullivan Christopher Ryan

Sullivan Christopher Ryan, CFO, reported a transaction classified as grant at Avalo Therapeutics, Inc. involving 163000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 163000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACFO
AVTXAvalo Therapeutics, Inc.
Filing timeJan 30
Trade dateJan 28, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

AVTX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
AVTX since 2025-01-30Filed 581 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001578563-25-000028
Stock Option (Right to Buy)
Transaction date
Jan 28, 2025
Filed Jan 30, 2025, 10:43 PM · 2d delay
Shares
163k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
163k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Derivative Transaction Direct Ownership Large Holdings Increase
-6score
Filing-only score

-6

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Financial Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The stock option vests twenty-five percent (25%) on January 28, 2026 and the remainder will vest in equal monthly installments over the following three (3) years, subject to the Reporting Person's con…

Original filing · 0001578563-25-000028
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

AVTX